Healthcare of Ontario Pension Plan Trust Fund Acquires New Holdings in The Procter & Gamble Company (NYSE:PG)

Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of The Procter & Gamble Company (NYSE:PG) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 790,000 shares of the company’s stock, valued at approximately $136,828,000.

A number of other hedge funds and other institutional investors have also modified their holdings of PG. International Assets Investment Management LLC raised its stake in shares of Procter & Gamble by 19,030.8% during the third quarter. International Assets Investment Management LLC now owns 3,693,593 shares of the company’s stock valued at $639,730,000 after purchasing an additional 3,674,286 shares in the last quarter. Wulff Hansen & CO. raised its stake in shares of Procter & Gamble by 16,292.0% during the second quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company’s stock valued at $606,230,000 after purchasing an additional 3,653,477 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG acquired a new position in Procter & Gamble during the third quarter worth about $301,950,000. AMF Tjanstepension AB grew its holdings in Procter & Gamble by 416.1% during the third quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock worth $315,016,000 after acquiring an additional 1,466,115 shares during the period. Finally, Swedbank AB acquired a new position in Procter & Gamble during the first quarter worth about $233,788,000. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Trading Up 1.1 %

NYSE:PG opened at $179.31 on Wednesday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $179.46. The stock’s 50-day moving average is $170.11 and its two-hundred day moving average is $168.83. The stock has a market cap of $422.28 billion, a PE ratio of 30.92, a price-to-earnings-growth ratio of 3.82 and a beta of 0.42.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm’s revenue was down .6% on a year-over-year basis. During the same period in the previous year, the company earned $1.83 EPS. As a group, equities research analysts forecast that The Procter & Gamble Company will post 6.96 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.25%. Procter & Gamble’s dividend payout ratio is 69.48%.

Analyst Ratings Changes

PG has been the topic of a number of research analyst reports. DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a report on Thursday, August 29th. Evercore ISI lifted their target price on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Wolfe Research raised Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Barclays lowered Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price on the stock. in a report on Monday, September 30th. Finally, Morgan Stanley lifted their price target on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. Eight research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $180.45.

Insider Activity

In related news, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the sale, the insider now directly owns 11,566 shares in the company, valued at approximately $1,954,538.34. The trade was a 52.53 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Jon R. Moeller sold 7,007 shares of the business’s stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $1,202,751.55. Following the completion of the sale, the chief executive officer now owns 269,172 shares of the company’s stock, valued at approximately $46,203,373.80. This trade represents a 2.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 35,233 shares of company stock worth $6,024,234 in the last three months. 0.18% of the stock is owned by insiders.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.